Publications
|
|
2024
Ahn JH, da Silva Pedrosa M, Lopez LR, Tibbs TN, Jeyachandran J, Vignieri EE, Rothemich A, Cumming I, Irmscher AD, Haswell CJ, Zamboni WC, Yu Y- RA, Ellermann M, Denson LA, Arthur JC. Intestinal E. coli - produced yersiniabactin promotes pro-fibrotic macrophages in Crohn’s disease. Cell Host and Microbe. 2025 Jan 8; 33(1):P71-88.E9. doi: 10.1016/j.chom.2024.11.012.
Heavey MK, Hazelton A, Wang Y, Garner M, Anselmo A, Arthur JC*, Nguyen J*. (2024) Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis. Nature Communications, May 6;15(1):3784. PMC11074276. *Co-corresponding authors.
Heavey MK, Hazelton A, Wang Y, Garner M, Anselmo A, Arthur JC*, Nguyen J*. (2024) Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis. Nature Communications, May 6;15(1):3784. PMC11074276. *Co-corresponding authors.
2023
Bleich RM, Li C, Sun S, Ahn JH, Dogan B, Barlogio CJ, Broberg CA, Franks AR, Bulik-Sullivan E, Carroll IM, Simpson KW, Fodor AA, Arthur JC. A consortia of clinical E. coli strains with distinct in vitro adherent/invasive properties establish their own co-colonization niche and shape the intestinal microbiota in inflammation-susceptible mice. Microbiome. 2023 Dec 20;11(1):277. doi: 10.1186/s40168-023-01710-y. PMID: 38124090; PMCID: PMC10731797.
Lopez LR, Miller CM, Jeyachandran JN, Li C, Simpson KW, Arthur JC. Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance. Microbiol Spectr. 2023 Jun 15;11(3):e0350022. doi: 10.1128/spectrum.03500-22. Epub 2023 May 15. PMID: 37184392; PMCID: PMC10269711.
Wang, M., Rousseau, B., Qiu, K. et al. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-01957-8.
Lopez LR, Miller CM, Jeyachandran JN, Li C, Simpson KW, Arthur JC. Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance. Microbiol Spectr. 2023 Jun 15;11(3):e0350022. doi: 10.1128/spectrum.03500-22. Epub 2023 May 15. PMID: 37184392; PMCID: PMC10269711.
Wang, M., Rousseau, B., Qiu, K. et al. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-01957-8.
2022
Lopez Lacey R., Ahn Ju-Hyun, Alves Tomaz, Arthur Janelle C. Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology. 2022 vol 12. DOI=10.3389/fcimb.2022.934619
Hoffner O'Connor M, Berglind A, Kennedy Ng MM, Keith BP, Lynch ZJ, Schaner MR, Steinbach EC, Herzog J, Trad OK, Jeck WR, Arthur JC, Simon JM, Sartor RB, Furey TS, Sheikh SZ. BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent Colitis. Front Immunol. 2022 Mar 24;13:856966. doi: 10.3389/fimmu.2022.856966. PMID: 35401533; PMCID: PMC8988134.
Hoffner O'Connor M, Berglind A, Kennedy Ng MM, Keith BP, Lynch ZJ, Schaner MR, Steinbach EC, Herzog J, Trad OK, Jeck WR, Arthur JC, Simon JM, Sartor RB, Furey TS, Sheikh SZ. BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent Colitis. Front Immunol. 2022 Mar 24;13:856966. doi: 10.3389/fimmu.2022.856966. PMID: 35401533; PMCID: PMC8988134.
2021
Wang J, Bleich RM, Zarmer S, Zhang S, Dogan B, Simpson KW, Arthur JC. Long-read sequencing to interrogate strain-level variation among adherent-invasive Escherichia coli isolated from human intestinal tissue. PLoS One. 2021 Oct 28;16(10):e0259141. doi: 10.1371/journal.pone.0259141. PMID: 34710159; PMCID: PMC8553045.
Lopez LR, Barlogio CJ, Broberg CA, Wang J, Arthur JC. A nadA mutation confers nicotinic acid auxotrophy in pro-carcinogenic intestinal Escherichia coli NC101. Frontiers in Microbiology. 2021 Jun 2 vol 12.
PDF
Bleich RM and Arthur JC. Microbiome and the Hallmarks of Cancer. In Jun Sun (eds), Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications. Springer Nature. Pages 1-26. ISBN 978-3-030-67951-4.
Lopez LR, Bleich RM, and Arthur JC. Microbiota Effects on Carcinogenesis: Initiation, Promotion, Progression. Annual Review of Medicine. 2021 Jan 27;72:243-261.
PDF
Lopez LR, Barlogio CJ, Broberg CA, Wang J, Arthur JC. A nadA mutation confers nicotinic acid auxotrophy in pro-carcinogenic intestinal Escherichia coli NC101. Frontiers in Microbiology. 2021 Jun 2 vol 12.
Bleich RM and Arthur JC. Microbiome and the Hallmarks of Cancer. In Jun Sun (eds), Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications. Springer Nature. Pages 1-26. ISBN 978-3-030-67951-4.
Lopez LR, Bleich RM, and Arthur JC. Microbiota Effects on Carcinogenesis: Initiation, Promotion, Progression. Annual Review of Medicine. 2021 Jan 27;72:243-261.
2020
Arthur JC. Microbiota and Colorectal Cancer: Colibactin Makes its Mark. Nat Rev Gastro and Hepatology. 2020 Jun;17(6):317-318. PMID 32317778.
PDF
2019
Ellermann M, Gharaibeh RZ, Fulbright L, Dogan B, Moore LN, Broberg CA, Lopez LR, Rothemich AM, Herzog JW, Rogala A, Gordan IO, Reider F, Brouwer CR, Simpson KW, Jobin C, Sartor RB, Arthur JC. Yersiniabactin producing AIEC promote inflammation-associated fibrosis in gnotobiotic IL10-/- mice. Infection and Immunity. Sept 3. PMID 31481410. *selected for cover illustration
PDF
Supplemental
Ellermann M, Gharaibeh RZ, Maharshak N, Peréz-Chanona E, Jobin C, Carroll IM, Arthur JC, Plevy SE, Fodor AA, Brouwer CR, Sartor RB. Dietary iron variably modulates assembly of the intestinal microbiota in colitis-resistant and colitis-susceptible mice. Gut Microbes. 2019 Jun 10;1-19. doi: 10.1080/19490976.2019.1599794. [Epub ahead of print] PubMed PMID: 31179826.
PDF
Supplemental
Tibbs TN, Lopez LL, Arthur JC. The influence of the microbiota on immune development chronic inflammation, and cancer in the context of aging. Microbial Cell. 2019 Aug 5;6(15):324-334. doi: 10.15698/mic2019.08.685. Epub 2019 May 13. PubMed Central PMCID: PMC6685047.
PDF
Bleich RM, Arthur JC. Revealing a microbial carcinogen. Science. 2019 Feb 15;363(6428):689-690. doi: 10.1126/science.aaw5475. PubMed PMID: 30765550.
PDF
Rothemich A, Arthur JC. (2019) The Azoxymethane/Il10 -/- Model of Colitis-Associated Cancer (CAC). In: Allen I. (eds), Mouse Models of Innate Immunity. Methods in Molecular Biology, Vol. 1960: Humana Press, New York, NY. Pp. 215-225. PMID 30798535.
Supplemental
Ellermann M, Gharaibeh RZ, Maharshak N, Peréz-Chanona E, Jobin C, Carroll IM, Arthur JC, Plevy SE, Fodor AA, Brouwer CR, Sartor RB. Dietary iron variably modulates assembly of the intestinal microbiota in colitis-resistant and colitis-susceptible mice. Gut Microbes. 2019 Jun 10;1-19. doi: 10.1080/19490976.2019.1599794. [Epub ahead of print] PubMed PMID: 31179826.
Supplemental
Tibbs TN, Lopez LL, Arthur JC. The influence of the microbiota on immune development chronic inflammation, and cancer in the context of aging. Microbial Cell. 2019 Aug 5;6(15):324-334. doi: 10.15698/mic2019.08.685. Epub 2019 May 13. PubMed Central PMCID: PMC6685047.
Bleich RM, Arthur JC. Revealing a microbial carcinogen. Science. 2019 Feb 15;363(6428):689-690. doi: 10.1126/science.aaw5475. PubMed PMID: 30765550.
Rothemich A, Arthur JC. (2019) The Azoxymethane/Il10 -/- Model of Colitis-Associated Cancer (CAC). In: Allen I. (eds), Mouse Models of Innate Immunity. Methods in Molecular Biology, Vol. 1960: Humana Press, New York, NY. Pp. 215-225. PMID 30798535.
2017
Fulbright LE, Ellermann M, Arthur JC. The microbiome and the hallmarks of cancer. PLoS Pathog. 2017 Sep;13(9):e1006480. doi: 10.1371/journal.ppat.1006480. eCollection 2017 Sep. Review. PubMed Central PMCID: PMC5608396.
PDF
Ellermann M, Arthur JC. Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic Biol Med. 2017 Apr;105:68-78. doi: 10.1016/j.freeradbiomed.2016.10.489. Epub 2016 Oct 22. Review. PubMed Central PMCID: PMC5401654.
PDF
Ellermann M, Carr JS, Fodor AA, Arthur JC, and Carroll IM. Characterizing and functionally defining the gut microbiota: Methodology and implications. In Floch, Ringel and Walker, The Microbiota in Gastrointestinal Pathophysiology: Implications for human health, prebiotics, probiotics and dysbiosis. Elsevier, Inc. 2017; 15-26.
Ellermann M, Arthur JC. Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic Biol Med. 2017 Apr;105:68-78. doi: 10.1016/j.freeradbiomed.2016.10.489. Epub 2016 Oct 22. Review. PubMed Central PMCID: PMC5401654.
Ellermann M, Carr JS, Fodor AA, Arthur JC, and Carroll IM. Characterizing and functionally defining the gut microbiota: Methodology and implications. In Floch, Ringel and Walker, The Microbiota in Gastrointestinal Pathophysiology: Implications for human health, prebiotics, probiotics and dysbiosis. Elsevier, Inc. 2017; 15-26.
2016
Monteagudo-Mera A, Arthur JC, Jobin C, Keku T, Bruno-Barcena JM, Azcarate-Peril MA. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Benef Microbes. 2016;7(2):247-64. doi: 10.3920/BM2015.0114. Epub 2016 Feb 3. PubMed Central PMCID: PMC4974821.
PDF
Supplemental
Supplemental
2014
Arthur JC, Gharaibeh RZ, Mühlbauer M, Perez-Chanona E, Uronis JM, McCafferty J, Fodor AA, Jobin C. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat Commun. 2014 Sep 3;5:4724. doi: 10.1038/ncomms5724. PubMed Central PMCID: PMC4155410.
PDF
Supplemental Figures
Supplemental Data
Supplemental Figures
Supplemental Data
2013
Baker K, Rath T, Flak MB, Arthur JC, Chen Z, Glickman JN, Zlobec I, Karamitopoulou E, Stachler MD, Odze RD, Lencer WI, Jobin C, Blumberg RS. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity. 2013 Dec 12;39(6):1095-107. doi: 10.1016/j.immuni.2013.11.003. Epub 2013 Nov 27. PubMed Central PMCID: PMC3902970.
PDF
Supplemental
McCafferty J, Mühlbauer M, Gharaibeh RZ, Arthur JC, Perez-Chanona E, Sha W, Jobin C, Fodor AA. Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model. ISME J. 2013 Nov;7(11):2116-25. doi: 10.1038/ismej.2013.106. Epub 2013 Jul 4. PubMed Central PMCID: PMC3806260.
PDF
Supplemental
Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep.2013 Oct 8;3:2868. doi: 10.1038/srep02868. PubMed Central PMCID: PMC3792409.
PDF
Arthur JC, Jobin C. The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes.2013 May-Jun;4(3):253-8. doi: 10.4161/gmic.24220. Epub 2013 Apr 2. PubMed Central PMCID: PMC3669172.
PDF
Allen IC, McElvania-TeKippe E, Wilson JE, Lich JD, Arthur JC, Sullivan JT, Braunstein M, Ting JP. Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis. PLoS One.2013;8(4):e60842. doi: 10.1371/journal.pone.0060842. Epub 2013 Apr 5. PubMed Central PMCID: PMC3618512.
PDF
Supplemental
McCafferty J, Mühlbauer M, Gharaibeh RZ, Arthur JC, Perez-Chanona E, Sha W, Jobin C, Fodor AA. Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model. ISME J. 2013 Nov;7(11):2116-25. doi: 10.1038/ismej.2013.106. Epub 2013 Jul 4. PubMed Central PMCID: PMC3806260.
Supplemental
Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep.2013 Oct 8;3:2868. doi: 10.1038/srep02868. PubMed Central PMCID: PMC3792409.
Arthur JC, Jobin C. The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes.2013 May-Jun;4(3):253-8. doi: 10.4161/gmic.24220. Epub 2013 Apr 2. PubMed Central PMCID: PMC3669172.
Allen IC, McElvania-TeKippe E, Wilson JE, Lich JD, Arthur JC, Sullivan JT, Braunstein M, Ting JP. Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis. PLoS One.2013;8(4):e60842. doi: 10.1371/journal.pone.0060842. Epub 2013 Apr 5. PubMed Central PMCID: PMC3618512.
2012
Chen L, Chen Z, Baker K, Halvorsen EM, da Cunha AP, Flak MB, Gerber G, Huang YH, Hosomi S, Arthur JC, Dery KJ, Nagaishi T, Beauchemin N, Holmes KV, Ho JW, Shively JE, Jobin C, Onderdonk AB, Bry L, Weiner HL, Higgins DE, Blumberg RS. The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction. Immunity. 2012 Nov 16;37(5):930-46. doi: 10.1016/j.immuni.2012.07.016. Epub 2012 Nov 1. PubMed Central PMCID: PMC3516394.
PDF
Supplemental
Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012 Oct 5;338(6103):120-3. doi: 10.1126/science.1224820. Epub 2012 Aug 16. PubMed Central PMCID: PMC3645302.
PDF
Holl EK, Roney KE, Allen IC, Steinbach E, Arthur JC, Buntzman A, Plevy S, Frelinger J, Ting JP. Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production. PLoS One. 2012;7(8):e43333. doi: 10.1371/journal.pone.0043333. Epub 2012 Aug 15. PubMed Central PMCID: PMC3419716.
PDF
Supplemental
Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, Jobin C, Rogers AB, Ting JP. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity. 2012 May 25;36(5):742-54. doi: 10.1016/j.immuni.2012.03.012. Epub 2012 Apr 12. PubMed Central PMCID: PMC3658309.
PDF
Supplemental
Gulati AS, Shanahan MT, Arthur JC, Grossniklaus E, von Furstenberg RJ, Kreuk L, Henning SJ, Jobin C, Sartor RB. Mouse background strain profoundly influences Paneth cell function and intestinal microbial composition. PLoS One.2012;7(2):e32403. doi: 10.1371/journal.pone.0032403. Epub 2012 Feb 27. PubMed Central PMCID: PMC3288091.
PDF
Supplemental
Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, Jobin C, Arthur JC, Corl BA, Vogel H, Storr M, Hontecillas R. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One. 2012;7(2):e31238. doi: 10.1371/journal.pone.0031238. Epub 2012 Feb 21. PubMed Central PMCID: PMC3283634.
PDF
Supplemental
Allen IC, Lich JD, Arthur JC, Jania CM, Roberts RA, Callaway JB, Tilley SL, Ting JP. Characterization of NLRP12 during the development of allergic airway disease in mice. PLoS One. 2012;7(1):e30612. doi: 10.1371/journal.pone.0030612. Epub 2012 Jan 23. PubMed Central PMCID: PMC3264608.
PDF
Supplemental
Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012 Oct 5;338(6103):120-3. doi: 10.1126/science.1224820. Epub 2012 Aug 16. PubMed Central PMCID: PMC3645302.
- Research Highlight: Kahrstrom CT, Nat Rev Microbiol. 2012 Oct;10(10):670
- Research Highlight: Ray, K, Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):558
- Selected Summary: Vetrano, S and Danese, S, Gastroenterology. 2013 Feb;144(2):461-3.
- Perspective: Schwabe, RF and Wang, TC, Science. 2012 Oct 5;338(6103):52-3
Holl EK, Roney KE, Allen IC, Steinbach E, Arthur JC, Buntzman A, Plevy S, Frelinger J, Ting JP. Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production. PLoS One. 2012;7(8):e43333. doi: 10.1371/journal.pone.0043333. Epub 2012 Aug 15. PubMed Central PMCID: PMC3419716.
Supplemental
Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, Jobin C, Rogers AB, Ting JP. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity. 2012 May 25;36(5):742-54. doi: 10.1016/j.immuni.2012.03.012. Epub 2012 Apr 12. PubMed Central PMCID: PMC3658309.
Supplemental
Gulati AS, Shanahan MT, Arthur JC, Grossniklaus E, von Furstenberg RJ, Kreuk L, Henning SJ, Jobin C, Sartor RB. Mouse background strain profoundly influences Paneth cell function and intestinal microbial composition. PLoS One.2012;7(2):e32403. doi: 10.1371/journal.pone.0032403. Epub 2012 Feb 27. PubMed Central PMCID: PMC3288091.
Supplemental
Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, Jobin C, Arthur JC, Corl BA, Vogel H, Storr M, Hontecillas R. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One. 2012;7(2):e31238. doi: 10.1371/journal.pone.0031238. Epub 2012 Feb 21. PubMed Central PMCID: PMC3283634.
Supplemental
Allen IC, Lich JD, Arthur JC, Jania CM, Roberts RA, Callaway JB, Tilley SL, Ting JP. Characterization of NLRP12 during the development of allergic airway disease in mice. PLoS One. 2012;7(1):e30612. doi: 10.1371/journal.pone.0030612. Epub 2012 Jan 23. PubMed Central PMCID: PMC3264608.
2011
Appleyard CB, Cruz ML, Isidro AA, Arthur JC, Jobin C, De Simone C. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol. 2011 Dec;301(6):G1004-13. doi: 10.1152/ajpgi.00167.2011. Epub 2011 Sep 8. PubMed Central PMCID: PMC3233787.
PDF
Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB, Jobin C. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis. 2011 Jan;17(1):289-97. doi: 10.1002/ibd.21366. PubMed Central PMCID: PMC2953593.
PDF
Arthur JC, Jobin C. The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis. 2011 Jan;17(1):396-409. doi: 10.1002/ibd.21354. PubMed Central PMCID: PMC3376405.
PDF
Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB, Jobin C. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis. 2011 Jan;17(1):289-97. doi: 10.1002/ibd.21366. PubMed Central PMCID: PMC2953593.
Arthur JC, Jobin C. The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis. 2011 Jan;17(1):396-409. doi: 10.1002/ibd.21354. PubMed Central PMCID: PMC3376405.
2010
Arthur JC, Lich JD, Ye Z, Allen IC, Gris D, Wilson JE, Schneider M, Roney KE, O'Connor BP, Moore CB, Morrison A, Sutterwala FS, Bertin J, Koller BH, Liu Z, Ting JP. Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol. 2010 Oct 15;185(8):4515-9. doi: 10.4049/jimmunol.1002227. Epub 2010 Sep 22. PubMed Central PMCID: PMC3641837.
PDF + Supplemental
PDF + Supplemental
2007
Arthur JC, Lich JD, Aziz RK, Kotb M, Ting JP. Heat shock protein 90 associates with monarch-1 and regulates its ability to promote degradation of NF-kappaB-inducing kinase. J Immunol. 2007 Nov 1;179(9):6291-6. doi: 10.4049/jimmunol.179.9.6291. PubMed PMID: 17947705.
PDF
Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, Ting JP. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol. 2007 Feb 1;178(3):1256-60. doi: 10.4049/jimmunol.178.3.1256. PubMed PMID: 17237370.
PDF
Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, Ting JP. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol. 2007 Feb 1;178(3):1256-60. doi: 10.4049/jimmunol.178.3.1256. PubMed PMID: 17237370.
2006
Lich JD, Arthur JC, Ting JP. Cryopyrin: in from the cold. Immunity. 2006 Mar;24(3):241-3. doi: 10.1016/j.immuni.2006.03.004. PubMed PMID: 16546091.
2005
Barouch DH, Yang ZY, Kong WP, Korioth-Schmitz B, Sumida SM, Truitt DM, Kishko MG, Arthur JC, Miura A, Mascola JR, Letvin NL, Nabel GJ. A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates. J Virol. 2005 Jul;79(14):8828-34. doi: 10.1128/JVI.79.14.8828-8834.2005. PubMed PMID: 15994776; PubMed Central PMCID: PMC1168733.
Barouch DH, Powers J, Truitt DM, Kishko MG, Arthur JC, Peyerl FW, Kuroda MJ, Gorgone DA, Lifton MA, Lord CI, Hirsch VM, Montefiori DC, Carville A, Mansfield KG, Kunstman KJ, Wolinsky SM, Letvin NL. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol. 2005 Mar;6(3):247-52. doi: 10.1038/ni1167. Epub 2005 Jan 30. PubMed PMID: 15685174.
Barouch DH, Powers J, Truitt DM, Kishko MG, Arthur JC, Peyerl FW, Kuroda MJ, Gorgone DA, Lifton MA, Lord CI, Hirsch VM, Montefiori DC, Carville A, Mansfield KG, Kunstman KJ, Wolinsky SM, Letvin NL. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol. 2005 Mar;6(3):247-52. doi: 10.1038/ni1167. Epub 2005 Jan 30. PubMed PMID: 15685174.
2004
Sumida SM, McKay PF, Truitt DM, Kishko MG, Arthur JC, Seaman MS, Jackson SS, Gorgone DA, Lifton MA, Letvin NL, Barouch DH. Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J Clin Invest. 2004 Nov;114(9):1334-42. doi: 10.1172/JCI22608. PubMed PMID: 15520866; PubMed Central PMCID: PMC524232.
Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J Immunol. 2004 May 15;172(10):6290-7. doi: 10.4049/jimmunol.172.10.6290. PubMed PMID: 15128818.
Sumida SM, Truitt DM, Kishko MG, Arthur JC, Jackson SS, Gorgone DA, Lifton MA, Koudstaal W, Pau MG, Kostense S, Havenga MJ, Goudsmit J, Letvin NL, Barouch DH. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. J Virol. 2004 Mar;78(6):2666-73. doi: 10.1128/jvi.78.6.2666-2673.2004. PubMed PMID: 14990686; PubMed Central PMCID: PMC353774.
Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J Immunol. 2004 May 15;172(10):6290-7. doi: 10.4049/jimmunol.172.10.6290. PubMed PMID: 15128818.
Sumida SM, Truitt DM, Kishko MG, Arthur JC, Jackson SS, Gorgone DA, Lifton MA, Koudstaal W, Pau MG, Kostense S, Havenga MJ, Goudsmit J, Letvin NL, Barouch DH. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. J Virol. 2004 Mar;78(6):2666-73. doi: 10.1128/jvi.78.6.2666-2673.2004. PubMed PMID: 14990686; PubMed Central PMCID: PMC353774.
